• ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2

    Jun 8, 2022, 09:19 by
    ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions are pleased to announce the development of a new antibody cocktail effective against major variants of SARS-CoV-2.
    Full story
  • Veeva Announces Clinical Study Training Application

    Jun 8, 2022, 09:19 by
    Veeva Systems announces new application, Veeva Vault Study Training, for integrated and automated clinical training.
    Full story
  • Abzena Selects IPS for Turnkey Delivery of New CGMP Facility in North Carolina

    Jun 8, 2022, 09:19 by
    IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina
    Full story
  • Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research

    Jun 8, 2022, 09:19 by
    Dolomite Bio launches new hydrogel focused reagent kits, enabling high-throughput encapsulation of cells in hydrogel scaffolds.
    Full story
  • Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022

    Jun 8, 2022, 09:19 by
    Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.
    Full story
  • Genetic Control Of Autoimmune Disease Mapped To Cellular Level

    Jun 8, 2022, 01:00 by User Not Found
    Clinical Research News | The pioneering OneK1K study in Australia has identified an immune “fingerprint” of seven autoimmune disorders using single-cell RNA sequencing (scRNA-seq). The general framework, which combines the scRNA-seq data with genotype data to classify individual cells, can be applied to many different diseases.
    Full story
  • DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

    Jun 7, 2022, 09:10 by
    DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.
    Full story
  • The Scope of Things: Jasmine Smith and Dr. Deborah Duong on the First Decentralized AI Longevity Research Network

    Jun 7, 2022, 01:00 by User Not Found
    Clinical Research News | With the latest innovations in medicine often prohibitively expensive, Rejuve.AI’s Jasmine Smith, CEO, and Dr. Deborah Duong, CTO, help patients achieve a healthy and extended lifespan regardless of economic standing. In the latest episode of the Scope of Things podcast, they, along with podcast host, Deborah Borfitz, discuss the world’s first decentralized AI longevity research network that provides equitable health and wellness solutions.
    Full story
  • Antibody-drug Conjugates Manufacturing and Future Focus

    Jun 6, 2022, 09:49 by
    ADCs demonstrated great potential for the treatment of cancers, and simultaneously require unique supporting infrastructure to meet biopharmaceutical industry standards for safe, effective, and reliable manufacturing.
    Full story
  • Full-Scale Mitochondrial Bioenergetics Services at Creative Biogene

    Jun 2, 2022, 14:32 by
    Creative Biogene provides partners with comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments.
    Full story
  • Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

    Jun 2, 2022, 09:12 by
    Full story
  • A New Phase of BOC Sciences Partnership Expansion Unlocked after TIDES USA 2022

    Jun 2, 2022, 09:12 by
    Full story
  • BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

    Jun 2, 2022, 09:11 by
    BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale.
    Full story
  • Guardant and IQVIA Develop Precision Oncology Platform to Normalize Clinical Data

    Jun 2, 2022, 01:00 by User Not Found
    Clinical Research News | Innovative Practices Award | Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and lengthy documents. That’s why the scientists at Guardant Health and Linguamatics, an IQVIA company, launched a real-world evidence database called GuardantINFORM. The platform was named one of the 2022 Bio-IT World Innovative Practices award winners.
    Full story
  • Huateng Pharma has the capability to rapidly produce key intermediates for antiviral drugs

    Jun 1, 2022, 09:38 by
    Huateng Pharma has the capabilities to perform process development and scale-up antiviral drug intermediates, eg. paxlovid intermediates.
    Full story
  • Chasing Digital Twins: Pilot Project Tackles Cancer Patient Twins in Neuro-Oncology

    Jun 1, 2022, 01:00 by User Not Found
    Clinical Research News | At the Bio-IT World Conference & Expo last month, a team of researchers reported on their 12-week pilot effort to build cancer patient digital twins to aid in oncologist decision-making.
    Full story
  • Biopharma PEG Supports mRNA Vaccine Delivery with The Production of PEG Derivatives for LNP System

    May 31, 2022, 10:05 by
    Biopharma PEG provides lab and GMP grade PEG lipids for the LNP systems in mRNA vaccines.
    Full story
  • CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues

    May 31, 2022, 10:05 by
    Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help researchers address some of the long-standing issues in drug development like drug solubility, bioavailability, and dissolution rate.
    Full story
  • World’s First Clinical Trials Ecosystem and Marketplace About To Open

    May 31, 2022, 01:00 by User Not Found
    Clinical Research News | As the world’s first clinical trial ecosystem and marketplace, ClinEco—launching in beta this summer—is designed to connect study sponsors in need of clinical trial support with the full range of clinical trial technology and service providers.
    Full story
  • BOC Sciences: A Robust Isotope Labeling Service Vendor

    May 27, 2022, 09:15 by
    BOC Sciences offers professional stable isotope labeling services to support worldwide partners from preclinical to commercial stages.
    Full story
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118 (current)
  • 119
  • 120
  • »